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Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt  
 
 
Stephan Wueest
1,2
, Reto A. Rapold
1,2
, Eugen J. Schoenle
1
, Daniel Konrad
1,2
 
 
1
Division of Pediatric Endocrinology and Diabetology, University Children's Hospital, CH-
8032 Zurich, Switzerland 
2
Zurich Center for Integrative Human Physiology, University of Zurich, CH-8057 Zurich, 
Switzerland 
 
 
 
Correspondence to: 
Daniel Konrad, M.D. Ph.D. 
University Children’s Hospital 
Department of Endocrinology and Diabetology 
Steinwiesstrasse 75 
CH-8032 Zurich 
Tel: ++41-44-266 7966; Fax: ++41-44-266 7983 
Email: daniel.konrad@kispi.uzh.ch 
 
 
Keywords: insulin resistance, Fas (CD95), 3T3-L1 adipocytes 
Abbreviations: AFasKO: adipocyte-specific Fas knockout; Fas-def: Fas deficient 
*Title, Cover Page and Abstract
Abstract 
Fas (CD95) belongs to the superfamily of the tumor necrosis factor (TNF) receptors. 
Besides its key role in apoptosis, Fas contributes to non-apoptotic pathways such as cell 
proliferation and inflammation. In 3T3-L1 adipocytes, activation of Fas by Fas ligand 
decreased insulin-stimulated glucose uptake, without affecting cell viability. This decrease in 
glucose uptake was accompanied by reduced protein expression and diminished 
phosphorylation of Akt. Similarly, insulin-stimulated glucose incorporation and protein levels 
of Akt were increased in isolated adipocytes from Fas deficient mice when compared to 
wildtype mice. In conclusion, Fas activation in adipocytes decreases Akt expression and 
thereby impairs insulin sensitivity. 
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1. Introduction 
Fas (CD95) belongs to the super family of the tumor necrosis factor (TNF) receptors, 
and plays a key role in the induction of apoptosis [1,2]. However, recent studies identified a 
novel role for Fas in non-apoptotic pathways such as cell proliferation and inflammation in 
several cell lines and tissues, similar to the action of TNFα. Accordingly, Fas activation was 
shown to induce secretion of pro-inflammatory cytokines like IL-1α, IL-1β, IL-8 (KC) or 
MCP-1 [3,4]. Likewise, we previously reported that activation of the Fas signalling pathway 
in 3T3-L1 adipocytes increased the production of pro-inflammatory cytokines such as IL-6 
and KC, without affecting cell viability [5]. Moreover, FasL-treated 3T3-L1 adipocytes 
became insulin resistant, as revealed by decreased insulin-stimulated glucose uptake and 
increased basal lipolysis [5]. However, the molecular mechanism involved in FasL-induced 
reduction in insulin-stimulated glucose uptake in 3T3-L1 adipocytes is not clear, and the 
present study seeks to unravel this mechanism. We demonstrate that Fas activation in 3T3-L1 
adipocytes reduces Akt/PKB transcription and expression and diminishes phosphorylation of 
Akt (Thr308 and Ser 473) as well as of its downstream target AS160 (Thr642). Moreover, 
FasL-induced insulin-resistance in 3T3-L1 adipocytes is reversible, and adipocytes isolated 
from Fas-deficient (Fas-def) mice show increased insulin-stimulated glucose incorporation 
compared to WT adipocytes paralleled by higher expression levels of Akt. 
 
  
*Manuscript text (starting from the introduction)
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2. Materials and methods 
 
Animals 
C57BL/6J wild-type and total body Fas-deficient (Fas-def) mice backcrossed for >10 
generations onto this same C57BL/6J inbred strain background (B6.MRL
lpr
) were obtained 
from The Jackson Laboratory. Adipocyte-specific Fas knockout (AFasKO) mice were 
generated as described [5]. All mice were housed in a specific pathogen-free environment on 
a 12-hour
 
light-dark cycle and fed a high fat diet (HFD) (D12331, Research Diets, New 
Brunswick, USA). All protocols conformed to the Swiss animal protection laws and were 
approved by the Cantonal Veterinary Office in Zurich, Switzerland. 
 
Fat explants 
White adipose tissue (retroperitoneal) was collected from wild type and AFasKO mice 
[5]. Pads were rinsed in DMEM (4.5 g/L D-glucose, Invitrogen, Basel, Switzerland) 
containing 0.5% bovine serum albumin (Merck, Geneva, Switzerland) and minced into pieces 
of 2 cm
2
 size and incubated for an hour at 37° C and 5% CO2. After washing three times, fat 
pads were incubated over night with 5ng/ml FasL at 37°C. After incubation, pads were 
washed three times with DMEM, and then incubated with or without 100 nM insulin for 20 
min. After washing in PBS, pads were snap frozen in liquid nitrogen and stored at -80° upon 
lysis. 
 
Glucose incorporation into isolated adipocytes and glucose uptake by 3T3-L1 adipocytes 
Adipocyte isolation and glucose incorporation was performed as described previously 
[6,7]. Glucose uptake by 3T3-L1 adipocyte was determined as described [8]. Mature 3T3-L1 
adipocytes were incubated with 2ng/ml membrane-bound FasL (Upstate, Lake Placid, NY, 
USA) for 12 hours. For the last 3 hours of incubation, cells were starved in FCS-free medium 
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(DMEM, 5 mM glucose). Thirty minutes before glucose uptake, insulin (1nM or 100nM) was 
added to the medium as indicated. 
 
Extraction of plasma membranes 
Mature 3T3-L1 adipocytes were homogenised in a buffer containing 20 mM HEPES, 
250 mM sucrose, 5 mM NaN3, 1mM EDTA, 0.2 mM PMSF and a 1: 1000 dilution protease 
inhibitor cocktail (Sigma). Lysates were centrifuged at 1’300 g for 10 minutes at 4° C. 
Thereafter, supernatant was centrifuged at 229’000 g for 90 minutes at 4° C (Kontron 
Instruments, Schlieren, Switzerland). Pellet was resuspended in 100 μl homogenization buffer 
and syringed 25 times (1ml syringe, 25G5/8).  
 
Western blotting 
Cell lysates and tissue samples were homogenized and Western blotting was 
performed as described previously [5]. The following primary antibodies were used: Anti-
phospho-Akt (Thr308), anti-phospho-Akt (Ser473), anti-Akt (Cell signalling, Beverly, MA, 
USA); anti-phospho-AS160, anti-IRS-1, anti-IR, anti-PPARγ2 (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA); anti-GLUT4 and anti-GLUT1 (gift from Dr. A. Klip, The Hospital for 
Sick Children, Toronto, ON, Canada); anti-Fas, anti-AS160 and anti-phospho IRS-1 (Ser 307)  
(Upstate, Lake Placid, NY, USA). Membranes were exposed in an Image Reader and 
analyzed with Image Analyzer (FujiFilm, Dielsdorf, Switzerland). 
 
RNA extraction and quantitative RT-PCR 
Total RNA was extracted using the NucleoSpin Kit (Macherey-Nagel, Oensingen, 
Switzerland) and RT-PCR was performed as described [5]. Akt2 PCR primers 
Mm00545827_m1 and Mm02026778_g1 were purchased from Applied Biosystems.  
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Viability assay 
Mature 3T3-L1 adipocytes were incubated for 12 hours with 2ng/ml FasL. Thereafter, 
cells were incubated with 0.5 mg/ml 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT, Sigma) for one hour. Salt was extracted from the cells with DMSO. The 
amount of yellow MTT reduced to purple formazan was measured spectrophotometrically.  
 
Data analysis 
Data are presented as means +/- SEM and were analyzed by Student’s t test, one 
sample t test or by analysis of variance (ANOVA) with a Tukey correction for multiple group 
comparisons.
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3. Results 
 
Fas (CD95) activation in 3T3-L1 adipocytes reduces insulin-stimulated glucose uptake 
Fas (CD95) receptor is expressed in 3T3-L1 adipocytes as well as in isolated 
adipocytes of WT mice, but not in adipocytes of adipocyte-specific Fas knockout (AFasKO) 
mice (Fig. 1A). Moreover, incubation of 3T3-L1 adipocytes with 2ng/ml of membrane-bound 
FasL for 12 hours decreased-insulin stimulated glucose uptake in 3T3-L1 adipocytes at 
different insulin concentrations (1nM and 100 nM) without affecting cell viability, while a 
concentration of 1 ng/ml FasL had no effect on glucose uptake (Fig. 1B/C). 
Intracellular contents of proteins involved in the insulin signaling pathway were 
analyzed next. Incubation of 3T3-L1 adipocytes with 2ng/ml FasL for 12 hours had no effect 
on IR, IRS-1, pIRS-1 (Ser307), total AS160, GLUT4 and GLUT1 levels (Fig. 2A and Tab. 1). 
However, levels of phosphorylated Akt (Thr308 and Ser473) as well as of total Akt were 
significantly down regulated upon Fas activation (Fig. 2A and Tab. 1). Interestingly, the ratio 
of phosphorylated Akt to total Akt was not affected upon Fas activation, suggesting that Fas 
activation reduces primarily Akt expression and does not directly interfere with insulin 
signaling upstream of Akt (Fig. 2B). In order to investigate whether decreased pAkt levels 
lead to reduced propagation of the insulin signal, phosphorylation of one of Akt’s downstream 
target, AS160, was determined. Indeed, incubation of 3T3-L1 adipocytes with 2 ng/ml FasL 
for 12 hours attenuated phosphorylation of AS160 on Thr642 (Fig. 2A and Tab. 1) without 
affecting total AS160 levels (Fig. 2C), suggesting impaired insulin signaling downstream of 
Akt. To explore whether Fas activation affects transcript levels of Akt, mRNA levels of Akt 
were determined in untreated and FasL-treated 3T3-L1 adipocytes. Transcript levels of Akt2, 
the most abundant and for glucose metabolism most important Akt isoform in adipocytes [9], 
were significantly down regulated upon FasL incubation (Fig. 2D), demonstrating that Fas 
activation down regulates Akt expression on transcriptional level. To investigate whether Fas 
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activation has an effect mRNA stability of Akt2, half life time (t1/2) of the mRNA of 
untreated and FasL-treated cells was determined. As shown in Figure 2E, t1/2 was 
diminished. However this difference did not reach statistical significance (8.4±1.5h in 
untreated vs. 5.2±0.6h in treated cells; p = 0.12). Hence, although there is a trend to decreased 
mRNA stability upon FasL treatment, these data suggest that Fas activation in 3T3-L1 
adipocytes may also decrease Akt2 mRNA transcription. 
 
Impaired insulin-stimulated glucose uptake into 3T3-L1 adipocytes upon Fas activation is 
reversible 
The similar viability of FasL-treated and untreated cells (Fig. 1C), as well as the fact 
that many proteins of the insulin signalling pathway were not affected by Fas activation (Fig. 
2A and Tab. 1) suggested that incubation of 3T3-L1 adipocytes with 2ng/ml FasL for 12 
hours activated mostly non-apoptotic processes. To further support this idea, experiments to 
determine the reversibility of FasL-induced alterations was performed. 3T3-L1 adipocytes 
were incubated with 2ng/ml FasL for 12 hours; thereafter cells were washed with PBS, and 
were recovered in media (DMEM, 5 mM glucose) without FasL for 9 hours. Upon recovery, 
the reduction in insulin-stimulated glucose uptake was reverted (Fig. 3A), suggesting that 
3T3-L1 adipocytes were not determined to apoptosis after incubation with 2ng/ml FasL for 12 
hours. Similarly, phosphorylation of Akt (Thr308) recovered, accompanied by restoration of 
total Akt levels (Fig. 3B). 
 
Membrane-bound FasL signals via Fas receptor 
To check whether the observed effects of FasL treatment on 3T3-L1 adipocytes were 
specific to the activation of the Fas receptor and not to (unspecific) effects, e.g. via activation 
of the TNF-receptor, experiments were performed in fat explants harvested from AFasKO 
mice. As expected, Fas expression was reduced in white adipose tissue of AFasKO mice 
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compared to WT (Supplemental Figure 1). However since Fas is still expressed in the stromal 
vascular fraction of adipose tissue, Fas is still present in adipose tissue of AFasKO mice [5], 
while it is almost completely absent in isolated adipocytes (Fig. 1A). Whereas incubation of 
fat explants with FasL from WT mice decreased Akt phosphorylation (Thr308) (Supplemental 
Figure 1), similar to what was observed in 3T3-L1 adipocytes (Fig. 2A), FasL treatment had 
no effect on Akt phosphorylation in fat explants from AFasKO mice (Supplemental Figure 1). 
Such data therefore suggest that the membrane-bound FasL used in this study signals 
specifically via the Fas receptor. 
 
Akt expression and insulin-stimulated glucose incorporation are increased in Fas-def 
adipocytes 
To investigate whether Fas activation in adipocytes has an effect on Akt expression in 
vivo, expression levels of Akt were analyzed in isolated adipocytes of WT and Fas-def mice 
fed a high fat diet (HFD) for 6 weeks. We previously showed that Fas is up regulated in 
adipocytes of WT mice upon 6 weeks of HFD [5]. As shown in Figure 4A, deletion of Fas 
from adipocytes resulted in significantly increased Akt expression compared to WT 
adipocytes. In addition, insulin-stimulated (0.5 and 100 nM) glucose incorporation into 
adipocytes isolated from Fas-def mice was preserved (Fig. 4B), suggesting improved insulin 
sensitivity due to higher Akt levels.  
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4. Discussion 
Fas (CD95), a member of the TNF receptor super family, is a major contributor to 
apoptosis in many cells. Findings over the last years, however, revealed that activation of the 
Fas signalling pathway can evoke non-apoptotic responses in different cells, similar to the 
action of TNFα [3-5]. We recently provided evidence that activation of Fas may contribute to 
obesity-induced insulin resistance since mice lacking Fas in adipocytes were partly protected 
from developing insulin resistance. In particular, Fas activation led to increased release of 
pro-inflammatory cytokines, and reduced insulin-stimulated glucose uptake in 3T3-L1 
adipocytes [5]. The aim of the present study was to further characterize the mechanism 
involved in the latter. Here we show that Fas activation in 3T3-L1 adipocytes decreased Akt 
mRNA levels by reducing its transcription (Fig. 2D/E) and, subsequently, protein content. 
Consequently, reduction in Akt protein levels led to reduced propagation of the insulin signal 
as manifested by decreased phosphorylation of AS160 albeit its protein levels were not 
significantly decreased. Similar reduction of total Akt and pAkt protein levels (Fig. 2A/B and 
Tab. 1) upon FasL stimulation suggests that insulin signalling is not altered upstream of Akt. 
Accordingly, levels of IR, IRS-1 and pS307 IRS-1 were not affected by the activation of the 
Fas signalling pathway in 3T3-L1 adipocytes (Fig. 2A and Tab. 1).  
Similar findings of reduced Akt levels were reported for the activation of the TNFα 
pathway in 3T3-L1 adipocytes [10]. However, TNFα levels were not increased in the 
supernatant of 3T3-L1 adipocytes treated for 12 hours with FasL (45.2 ± 1.0 pg/ml in 
untreated vs. 47.4 ± 0.7 pg/ml in FasL-treated cells). In addition, we show herein that 
membrane-bound FasL signals specifically via the Fas receptor, as FasL-incubation of fat 
pads harvested from AFasKO mice had no effect on the phosphorylation of Akt 
(Supplemental Figure 1). Therefore, neither a paracrine TNFα effect nor signalling of FasL 
via the TNF receptor is responsible for the observed effects. Possibly, increased release of 
cytokines like IL-6 upon Fas activation contributes to reduced insulin-stimulated glucose 
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uptake in 3T3-L1 adipocytes [5]. However, IL-6 was shown to impair glucose uptake via 
down regulation of GLUT4 [11], an effect that we did not observe in FasL-treated cells 
(Figure 2A and Tab. 1). In addition, FasL-induced inhibition of glucose uptake could not be 
reverted using a neutralizing IL-6 antibody (data not shown). Moreover, Fas-activation 
induced secretion of IL-6 into the supernatant was only observed after 6 hours of incubation 
(Supplemental Figure 2), whereas Akt mRNA was already decreased upon 3 hours of FasL 
incubation (Fig. 2D). These data suggest that increased IL-6 secretion is not involved in 
decreased Akt mRNA transcription upon Fas activation. What could be the mechanism of 
reduced Akt transcription upon FasL incubation in 3T3-L1 adipocytes? Fas activation was 
previously shown to activate the NF-B, JNK and ERK signalling pathways in several cells 
and therefore to affect transcription [12]. However, incubation of 3T3-L1 adipocytes with 
membrane-bound FasL did neither activate the NF-B signalling pathway (Supplemental 
Figure 3) nor the JNK pathway (data not shown). In contrast, incubation of 3T3-L1 
adipocytes with 2ng/ml FasL activated the ERK signalling pathway. Inhibition of ERK 
activation with the MEK inhibitor U0126 during FasL incubation, however, could not prevent 
Fas-activation induced Akt down regulation (data not shown). Hence, three presently known 
transcription pathways induced by Fas activation could be excluded as potential contributors 
to the observed effects in 3T3-L1 adipocytes. Akt2 promotor analysis [Web ref.] suggests that 
PPARγ binds to the promotor region of Akt2. Treatment of 3T3-L1 adipocytes with FasL 
significantly reduces PPARγ protein levels (Supplemental Figure 4). Interestingly, increased 
activation of PPARγ by treatment with rosiglitazone prevented Fas-induced down regulation 
of Akt2 mRNA (Supplemental Figure 4), suggesting that reduced PPARγ levels upon Fas 
activation might be involved in reduced Akt2 transcription. Moreover, besides reducing Akt2 
transcription, Fas activation might also reduce mRNA stability of Akt2 (Fig. 2E). 
Activation of the Fas signalling pathway may contribute to obesity-induced insulin-
resistance of adipocytes [5]. Consistent with such notion, insulin-stimulated glucose 
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incorporation into isolated adipocytes from Fas-def mice was increased and paralleled by 
enhanced expression of Akt, suggesting that the absence of Fas prevented adipocytes from 
Fas-induced down regulation of Akt and, therefore, decreased insulin sensitivity. In addition, 
reduced expression of pro-inflammatory cytokines in WAT of Fas-def mice may have 
contributed to increased insulin sensitivity of adipocytes. Further studies are needed to 
unravel this question.  
In conclusion, our results suggest that Fas activation in adipocytes decreases Akt 
expression and, therefore, reduces insulin-stimulated glucose uptake/incorporation.
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7. Figure Legends  
 
Figure 1 Fas activation impairs insulin-stimulated glucose uptake 
(A) Lysates were prepared from mature 3T3-L1 adipocytes and from isolated white 
adipocytes, resolved by LDS-PAGE and immunoblotted with anti-Fas antibody. (B) Mature 
3T3-L1 adipocytes were incubated without (open bars), with 1 ng/ml (grey bars), or 2 ng/ml 
(black bars) FasL for 12 hours and glucose uptake was determined as outlined in the Material 
and Methods section. Results are the mean ± SEM of 4-9 independent experiments. *p < 0.05; 
***p < 0.0005 (ANOVA). (C) Mature 3T3-L1 adipocytes were incubated for 12 hours with or 
without 2ng/ml FasL. Thereafter, yellow MTT reduced to purple formazan was measured 
spectrophotometrically (550nm – 655nm). Results are the mean ± SEM of 3 independent 
experiments.  
 
Figure 2 Fas activation down regulates Akt expression 
(A) Total lysates of untreated and FasL treated (2ng/ml for 12 hours) 3T3-L1 adipocytes were 
resolved by LDS-PAGE and immunoblotted with respective antibodies. Total membrane 
lysates were used for immunoblotting with GLUT4 and GLUT1 antibody. (B) Expression 
levels of phosphorylated, total and the ratio of phosphorylated to total Akt (B) and AS160 (C) 
was calculated in untreated and FasL treated (12 hours) cells. Results are the mean ± SEM of 
3 to 6 independent experiments. *< 0.05; **p < 0.01 (one sample t test). (D) mRNA 
expression of Akt2 in 3T3-L1 adipocytes treated without (open bar) or with (black bars) FasL 
for 3, 6, and 9 hours. Results are the means ± SEM of three independent experiments. **p < 
0.01, ***p < 0.001 versus untreated control (one sample t test). (E) Mature 3T3-L1 
adipocytes treated with 5 µg/ml actinomycin D (ActD; Sigma) for various time periods (0h, 
1.5h, 3h and 9h) were incubated either with (filled circles) or without (open circles) FasL. 
mRNA expression of Akt2 was determined with two different set of primers (shown are 
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results for one primer) and linear regression analysis (dotted line) was performed to calculate 
t1/2. Results are the means ± SEM of three independent experiments.  
 
Figure 3 Recovery of Akt restores insulin-stimulated glucose uptake 
(A) Mature 3T3-L1 adipocytes were incubated with (black bars; FasL) or without (open bars; 
Co) 2 ng/ml FasL for 12 hours. Cells were then incubated with normal glucose medium 
(DMEM, 5 nM, 2% FCS) without FasL for 9 hours (hatched bars; Rev) and 2-Deoxyglucose 
glucose uptake was determined as outlined in Figure 1. Results are the mean ± SEM of 3 
independent experiments. * p < 0.05, ** p < 0.01 (ANOVA). (B) Total lysates of 3T3-L1 
adipocytes were treated as outlined in Figure 3A, stimulated with 100 nM human insulin for 
30 min, resolved by LDS-PAGE and immunoblotted with anti-pAkt (Thr308) or anti-Akt 
antibody. Results are the mean ± SEM of 3 independent experiments. *p < 0.05 (one sample t 
test, Student’s t test). 
 
Figure 4 Akt expression is increased in Fas-def adipocytes   
(A) Total cell lysates were prepared from isolated adipocytes of wild-type and Fas-def mice. 
Lysates were resolved by LDS-PAGE and immunoblotted with anti-Fas, anti-Akt or anti-actin 
antibody. Results represent the mean ± SEM of 4-5 experiments. *p < 0.05 (Student’s t test). 
(B)
 14
C-D-glucose incorporation into isolated adipocytes from HFD-fed WT (open bars) and 
Fas-def (black bars) mice was determined in the absence or presence of insulin as indicated. 
Shown are absolute values of glucose incorporation. Results represent the mean ± SEM of 6 
experiments. ***p < 0.001 (Student’s t test).  
 
 
Table 1 
Protein Control FasL 
IR 1.0 0.99 ± 0.19 
IRS-1 1.0 0.82 ± 0.25 
pS307 IRS-1 1.0 1.06 ± 0.16 
pAkt (Thr308) 1.0 0.52 ± 0.09** 
pAkt (Ser473) 1.0 0.63 ± 0.13* 
Akt 1.0 0.56 ± 0.07** 
pAS160 (Thr642) 1.0 0.34 ± 0.15* 
AS160 1.0 0.73 ± 0.3 
GLUT1 1.0 0.97 ± 0.15 
GLUT4 1.0 0.83 ± 0.07 
 
Values are means ± SEM of 3-10 independent experiments; *p < 0.05, **p < 0.01 (Student’s t 
test). 
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